BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BG Medicine 

40 Bear Hill Road

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-890-1199 Fax: 781-895-1119


SEARCH JOBS




Industry
Biotechnology






 Company News
BG Medicine (BGMD) Announces Q1 2014 Financial Results Release Date And Conference Call Information 5/8/2014 9:55:57 AM
BG Medicine (BGMD) Prices $10 Million Public Offering Of Common Stock 4/3/2014 8:18:02 AM
BG Medicine (BGMD) Announces Proposed Public Offering Of Common Stock 4/3/2014 8:16:19 AM
BG Medicine (BGMD) Release: Publication Reports Clinical Utility Of BGM Galectin-3® Test For Prediction Of Near-Term Rehospitalization In Patients With Heart Failure 3/25/2014 8:54:26 AM
BG Medicine (BGMD) Reports 2013 Fourth Quarter And Year End Financial Results 3/20/2014 9:29:08 AM
BG Medicine (BGMD) Announces Issuance Of Patent Covering Galectin-3 Testing For Cardiac Resynchronization Therapy 3/20/2014 9:24:22 AM
BG Medicine (BGMD) Announces Fiscal Year 2013 Financial Results Release Date And Conference Call Information 3/14/2014 9:24:57 AM
BG Medicine (BGMD) Compliant With NASDAQ Listing Requirements 3/12/2014 9:09:40 AM
BG Medicine (BGMD) Welcomes La Jolla Pharmaceutical Company (LJPC)'s Announcement Of Positive Top-Line Results Of Phase 2 Clinical Trial Of Novel Pharmaceutical Compound Targeting Galectin-3 In Chronic Kidney Disease 3/12/2014 7:18:05 AM
BG Medicine (BGMD) Welcomes Inclusion Of Galectin-3 In 2014 Indian Consensus Document On Cardiac Biomarkers 3/10/2014 9:55:03 AM
12345678910...